Lisinopril |
Prinivil; Zestril |
Image:Lisinopril.png Lisinopril Systematic (IUPAC) name 1-[6-amino-2- (1-carboxy-3-phenyl-propyl) amino-hexanoyl]pyrrolidine- 2-carboxylic acid dihydrate Identifiers CAS number 83915-83-7 ATC code C09AA03 PubChem 5362119 DrugBank APRD00560 Chemical data Formula C21H31N3O5 Mol. weight 405.488 g/mol Pharmacokinetic data Bioavailability approx. 25%, but wide range between individuals (6 to 60%) Protein binding 0 Metabolism none - eliminated unchanged in urine ...
Wikipedia - [full article]
Lisinopril Clinical Trials
- The Vascular Effects of Carvedilol CR + Lisinopril Versus Lisinopril + Hydrochlorothiazide in Abdominally Obese Hypertensive Patients
ClinicalTrials.gov Identifier: NCT00459056 - Recruiting
Abdominal Obesity; Hypertension
- The COREG And Lisinopril Combination Therapy In Hypertensive Subjects (COSMOS) Trial
ClinicalTrials.gov Identifier: NCT00347360 - Recruiting
Hypertension
- Study to Demonstrate the Bioequivalence of the Fixed Dose Combination of COREG CRâ„¢ and Lisinopril to Its Components
ClinicalTrials.gov Identifier: NCT00556920 - Recruiting
Hypertension
- Study to Examine the Effect of Food on the Pharmacokinetics of the Fixed Dose Combination of COREG CR and Lisinopril.
ClinicalTrials.gov Identifier: NCT00557128 - Recruiting
Hypertension
- Study to Investigate Dose Proportionality of the Fixed Dose Combination of COREG CR and Lisinopril.
ClinicalTrials.gov Identifier: NCT00549510 - Recruiting
Hypertension
- Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease
ClinicalTrials.gov Identifier: NCT00553969 - Recruiting
Pre-Hypertension; Cardiovascular Disease Prevention
- Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
ClinicalTrials.gov Identifier: NCT00000542 - Active, not recruiting
Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus; Heart Diseases; Hypercholesterolemia; Hypertension; Myocardial Infarction; ...
- Antiproteinuric Effect of Valsartan and Lisinopril
ClinicalTrials.gov Identifier: NCT00171574 - Completed
Hypertension; Diabetic Nephropathy
- VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With Microalbuminuria
ClinicalTrials.gov Identifier: NCT00171067 - Completed
Hypertension
- Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With Diabetes
ClinicalTrials.gov Identifier: NCT00241124 - Completed
Hypertension
- Cognitive/Cerebrovascular Consequences of HTN Treatment
ClinicalTrials.gov Identifier: NCT00151138 - Completed
Hypertension
- Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy
ClinicalTrials.gov Identifier: NCT00311870 - Completed
Diabetic Nephropathy
- A Clinical Study to Compare the Safety and Efficacy of an Aliskiren-Based Regimen With a Lisinopril Based Regimen in Patients With Severe Hypertension
ClinicalTrials.gov Identifier: NCT00219050 - Completed
Hypertension
- Study of Drugs for High Blood Pressure and High Cholesterol in American Indians with Type 2 Diabetes at High Risk of Kidney or Heart Disease
ClinicalTrials.gov Identifier: NCT00004266 - Completed
Diabetic Nephropathy
- Antialbuminuric Effects of Valsartan and Lisinopril
ClinicalTrials.gov Identifier: NCT00171600 - Terminated
Hypertension; Early Diabetic Nephropathy
- Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease
ClinicalTrials.gov Identifier: NCT00118976 - Completed
Diabetes Mellitus, Type I; Diabetic Nephropathy
- COREG MR Versus Toprol-XL® On Reduction of Microalbuminuria in Patients with Hypertension and Microalbuminuria
ClinicalTrials.gov Identifier: NCT00123903 - Terminated
Hypertension; Albuminuria

Not Signed In -


